ENT
-
Feb- 2020 -18 February
What is Cohort Study- DNB ENT Theory Question
Cohort Study Observational/Analytical studyObtain evidence to support or refute existence of association between a cause and diseaseUsually Prospective study/ Longitudinal study/ “Forward looking study”Follow up at different time points, while actively looking for the outcomeCause to effectEg.: Role of exposure to dyes in development of Bladder cancer Points Cohorts identified…
Read More » -
18 February
What is Case Control Study – ENT Theory Question
Case Control Study is a study that compares patients who have a disease (cases) with patients who do not have the disease (controls), and looks back retrospectively to compare how frequently the exposure to a risk factor is present in each group to determine the relationship between the risk factor…
Read More » -
18 February
Sensitivity and Specificity – DNB ENT Theory Question
SENSITIVITY VS SPECIFICITY Screening tests are those tests done among apparently well people to identify those at an increased risk of a disease or disorder. Those patients who are identified by a screening test are then offered a subsequent diagnostic test or procedure, or in some instances, a treatment or…
Read More » -
16 February
BRANCHIO-OTO-RENAL SYNDROME – Short Question DNB ENT
The branchio-oto-renal syndrome (BOR) or Melnick-Fraser Syndrome is an uncommon but well defined constellation of branchial arch anomalies (brancial fistulas, branchial cysts), external ear malformations with hearing loss and renal hypoplasia or dysplasia*. It has an autosomal dominant transmission pattern with variable clinical expression. Around 80 mutations in EYA1, the…
Read More » -
Jan- 2020 -19 January
CHARTS and CLASSIFICATIONS IN PEDIATRIC ENT
classification in pedia orl 1 page 02 classification in pedia orl 1 page 03 To read full content, please consider buying the membership View PlansAvailable PlansPlus Plan₹1,499.00Read Premium content -Valid for 12 months -Access to Exclusive WebinarsPro Plan₹799.00Read Premium content -Valid for 6 months -Access to Exclusive WebinarsNextPrevious * Username…
Read More »